-
Sector Analysis
Contract Pharmaceutical Dose Manufacturing Industry – Composition, Size, Market Share and Outlook, 2023 Edition
Contract Pharmaceutical Dose Manufacturing Industry Overview The total dose CMO contract revenue in 2022 represented significant growth over 2021 revenue. The growth rate was the highest recorded since 2011 for commercial contract dose manufacturing revenues, and surprisingly adds to the strong growth experienced in 2021, despite demand for COVID-19 vaccines and therapies waning in 2022. The Contract Pharmaceutical Dose Manufacturing Industry report is a comprehensive look at the finished dose contract manufacturing landscape in 2023. It includes an analysis of...
-
Sector Analysis
IgA Nephropathy (Berger’s Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
IgA Nephropathy Competitive Analysis Report Overview IgA Nephropathy (Berger's disease) is an autoimmune disease that occurs when clumps of antibodies are deposited in the kidneys, causing inflammation and kidney damage. Clumps of IgA and other antibodies damage the glomeruli, tiny blood vessels in the kidneys that filter blood, causing the kidneys to leak blood and protein into the urine. The damage may also lead to scarring of the nephrons, the filtering units where the glomeruli are located. Key Mechanism of...
-
Product Insights
Nephron Pharma – Lexington County Pharmaceutical Plant Expansion – South Carolina
Equip yourself with the essential tools needed to make informed and profitable decisions with our Nephron Pharma - Lexington County Pharmaceutical Plant Expansion - South Carolina report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Sector Analysis
New Drug Approvals and Their Contract Manufacture – 2023 Edition
Explore actionable market insights from the following data in our ‘New Drug Approvals and Their Contract Manufacture’ report. This report is required reading for - CMO executives who must have a deep understanding of drug approvals and outsourcing to make strategic planning and investment decisions. Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management. Private equity investors who need a deeper understanding of the market to...
-
Sector Analysis
COVID-19: Contract Pharmaceutical Development and Manufacturing Relationships
This report examines contract manufacturing agreements for vaccines and therapies targeting COVID-19. It reports that there are more than 1,000 vaccines and therapies in development for COVID-19, and 36 vaccines and therapies approved (or granted emergency use authorization) for COVID-19 (as of report publication). At the beginning of the pandemic, slightly more than half of these agreements were for vaccines; this proportion has risen and continues to rise, as several vaccines have proven their safety and efficacy, received approval, and...